Kevin Chen, PharmD, MS, BCOP, CPP; and Amanda Cass, PharmD, BCPS, BCOP, share key insights about ROS1, non-small cell lung cancer, and the newly approved drug taletrectinib.
Amanda Cass, PharmD, BCPS, BCOP
Advertisement
Articles by Amanda Cass, PharmD, BCPS, BCOP
Advertisement
Latest Updated Articles
Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLCPublished: July 30th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Incidence of Invasive Fungal Infections Following BCMA-Directed CAR T-Cell Therapy in Multiple Myeloma
2
Is Berberine Nature’s GLP-1?
3
Meeting Patients Where They Are: How Pharmacists Are Helping People Stay on Track With Schizophrenia Treatment
4
Because Ned Said: America’s Growing Pharmacy Deserts Are Leaving Patients High and Dry
5
